Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1982
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1982
Report date:
1982
Reference Type:
other: Monograph
Title:
2,6-Dimethyl-2,4,6-Octatriene
Year:
1988
Bibliographic source:
Food and Chemical Toxicology 26 (4), 309

Materials and methods

Principles of method if other than guideline:
- Principle of test: Acute oral toxicity in Wistar rats
- Short description of test conditions: Ten male Wistar rats were used with initial body weights of 200-287 grams. Mortality and/or systemic effects were recorded 3-4 hours after dosing and daily thereafter for 14 days. Gross necropsy was carried out on all animals. LD50 was calculated by the method of Litchield and Wilcoxon.
- Parameters analysed / observed: LD50, mortality, systemic effects, gross necropsy
GLP compliance:
no
Test type:
other: Acute oral toxicity in Wistar rats
Limit test:
no

Test material

1
Chemical structure
Reference substance name:
(E,E)-2,6-dimethylocta-2,4,6-triene
EC Number:
221-153-1
EC Name:
(E,E)-2,6-dimethylocta-2,4,6-triene
Cas Number:
3016-19-1
Molecular formula:
C10H16
IUPAC Name:
(E,E)-2,6-dimethylocta-2,4,6-triene
Test material form:
liquid
Specific details on test material used for the study:
The test material (E,E)-2,6-dimethylocta-2,4,6-triene (EC 221-153-1) is the constituent of the registered substance.

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
Initial body weight of rats: 200-287 g

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
unchanged (no vehicle)
Doses:
1200, 3100 and 5000 mg/kg bw
No. of animals per sex per dose:
10
Control animals:
no

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 1 900 mg/kg bw
Based on:
test mat.
95% CL:
>= 1 600 - <= 2 300
Remarks on result:
other: Calculation method: Litchield and Wilcoxon
Sex:
male
Dose descriptor:
LD0
Effect level:
ca. 1 200 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD100
Effect level:
>= 3 200 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD100
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
1200 mg/kg bw: 0/10 deaths
1900 mg/kg bw: 5/10 deaths
3100 mg/kg bw: 10/10 deaths
5000 mg/kg bw: 10/10 deaths.
Clinical signs:
other: 1200 mg/kg bw: chromorhinorrhea, piloerection, lethargy, ptosis, chromodacryorrhea, ataxia and flaccid 1900 mg/kg bw: chromorhinorrhea, piloerection, lethargy, ptosis, chromodacryorrhea, ataxia and flaccid 3100 mg/kg bw: lethal - chromorhinorrhea, piloer
Gross pathology:
All dead animals had abnormalities in lungs, heart, kidneys, stomach, testes and/or intestine at necropsy.

Applicant's summary and conclusion

Conclusions:
The acute oral LD50 of 2,6-dimethyl-2,4,6-octatriene (CAS 3016-19-1) in Wistar male rats is 1900 mg/kg bw (95% C.I. 1600-2300 mg/kg body weight). Clinical signs observed were chromorhinorrhea, piloerection, lethargy, ptosis, chromodacryorrhea, ataxia and flaccid. Necropsy of dead animals revealed abnormalities in lungs, heart, kidneys, stomach, testes and/or intestines.
Executive summary:

The acute oral LD50 of 2,6-dimethyl-2,4,6-octatriene (CAS 3016-19-1) in Wistar male rats is 1900 mg/kg bw (95% C.I. 1600-2300 mg/kg body weight). Clinical signs observed were chromorhinorrhea, piloerection, lethargy, ptosis, chromodacryorrhea, ataxia and flaccid. Necropsy of dead animals revealed abnormalities in lungs, heart, kidneys, stomach, testes and/or intestines.